Annovis Raises $21M to Fund Pivotal Alzheimer’s Trial Readout
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) raised $21 million in a November stock offering to finance operations through a pivotal Alzheimer’s disease clinical trial readout scheduled for March …
Annovis Raises $21M to Fund Pivotal Alzheimer’s Trial Readout Read More